|
We asked 40 industry leaders,  Which of these countries do you believe will drive most
of pharma's growth over the next 12 months?
Click here to vote.
| USA |
28% |
China |
33% |
| Brazil |
13% |
| Japan |
5% |
| Germany |
3% |
| India |
18% |
|
|
 |
|
|
|
|
|
23 September, 2014
|
|
|
Investing in Africa: Study, Share, Act — and Grow
Is sub-Saharan Africa a jewel box of untapped assets for a growth-obsessed big Pharma? Some of the majors apparently think so. To identify some benchmarks for best practices in building a viable drugs business in Africa, we spoke to Steven Adjei, native Ghanaian and founding partner of a start-up business “incubator” firm focused on opportunities in the sub-Saharan region. Read more |
Pharma M&As: Diverse and Accelerating
There has never been as many different strategies being followed by pharmaceutical companies as we're seeing today, says Pharm Exec Editorial Advisor Peter Young. Here, Peter provides examples of how Big Pharma companies have shifted direction to follow very diverse paths... Read more
|
Ebola Crisis Could Spur Broader R&D Efforts
While public and private organizations are rising to the challenge of developing treatments to subdue Ebola, the world is watching to see if these efforts translate into broader R&D on drugs and preventives for other neglected tropical diseases (NTDs). Jill Wechsler reports ... Read more
|
European Pharma: Paying the Price of Pharmacovigilance
The European Medicines Agency claims the new pharmacovigilance legislation has “brought about the biggest change to the legal framework for human medicines” in Europe since the creation of the central agency itself in 1995. But drug manufacturers and other marketing authorization holders are complaining that they are shouldering an unfair proportion of the legislations’ high costs .... Read more
|
|
|
|
|
